Addition of Trilaciclib May Mitigate Myelosuppression in Patients With Small Cell Lung Cancer

Addition of Trilaciclib May Mitigate Myelosuppression in Patients With Small Cell Lung Cancer - Curetoday.com

- June 30, 2019

Addition of Trilaciclib May Mitigate Myelosuppression in Patients With Small Cell Lung Cancer Curetoday.com

Trilaciclib, an intravenous CDK 4/6 inhibitor, in combination with Hycamtin may reduce chemotherapy-induced myelosuppression in small cell lung cancer, ...

Search This Blog

Lung Cancer

Addition of Trilaciclib May Mitigate Myelosuppression in Patients With Small Cell Lung Cancer - Curetoday.com

Comments

Post a Comment

Popular posts from this blog

Beagles, other dogs could be used to help in early detection of lung cancers, study finds - Fox 32 Chicago

Not An Ordinary Cough: Lung Cancer Symptoms That You Might Neglect - International Business Times

Beagles, other dogs could be used to help in early detection of lung cancers, study finds - Fox 32 Chicago